Hence then, the article about aisa pharma receives fda orphan drug designation for aisa 021 for treatment of systemic sclerosis was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( AISA Pharma Receives FDA Orphan Drug Designation for AISA-021 for Treatment of Systemic Sclerosis )
Last updated :
Also on site :
- How Coachella’s Longest-Standing Sponsor Has Remained Relevant in the Age of Brand Activations
- 'We've lost our way': Clifton's operator gives up on downtown Los Angeles
- Iran has learned that the Strait of Hormuz is its strongest deterrent